oral administration of a single dose of the anorectic agent mazindol to obese subjects led to a significant improvement in oral glucose tolerance and a concomitant reduction in insulin secretion , but had no effect on the blood glucose and plasma insulin responses to glucose given intravenously .
C0024977
mazindol
C0028754
obese